Webinar Summary: A Conversation with NCI Acting Director, Dr. Douglas R Lowy
On June 1, 2015, Dr. Douglas R. Lowy, NCI Acting Director, addressed the research advocacy community to discuss the Institute’s budget process and cancer research priorities, including precision medicine and its potential to lead to better treatments.
Dr. Lowy's presentation to advocates followed the morning’s announcement of NCI’s Molecular Analysis for Therapy Choice (MATCH) trial, highlighted in his presentation.
In his remarks, Dr. Lowy broadly discussed the President’s budget proposal for the Precision Medicine Initiative and the proposed increase in funding for NCI and NIH. In closing, he outlined the federal budget cycle and highlighted NCI’s infrastructure and purchasing power.